Hospital for Special Surgery in New York City has pioneered a lot of innovation. This time it’s digital pathology. They’re all in with research and consultation and dawning with primary diagnostics, thanks to a jump-start from COVID-19, and a recent FDA clearance of Sectra Digital Pathology Solution for image viewing. 

In February and March 2020, the inevitable happened: COVID-19 came to the United States, hitting the country’s healthcare system like a 10-pound sledgehammer. 

Like a whirlwind, COVID-19 seemed to appear out of nowhere and completely disrupted the global community. Economies are stressed, industries are experiencing unprecedented changes, and governments are trying to manage it all.

Medical imaging volume was hit hard by the COVID-19 pandemic. Fortunately, as the old adage says, this too shall pass. But when? And what should practices being doing to prepare for the return?

Since the beginning of the COVID-19 pandemic, hospitals have reported that stroke and heart attack patients are staying home instead of seeking the medical attention they need. Medical societies have warned against such actions, highlighting the importance of seeking treatment, yet the trend continues throughout the United States.

Prospect, Connecticut, was founded all the way back in 1827, and its citizens take great pride in the city’s gorgeous scenery and deep history. In fact, just one look at Prospect’s motto—“The Best Small Town in Connecticut”—tells you everything you need to know.

The Alaska Native Medical Center (ANMC) is a 173-bed hospital located in Anchorage, Ala., working in close partnership with Alaska’s rural health facilities to support a broad range of healthcare and related services.

When the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) was signed into law in 2015, it answered the prayers of healthcare providers everywhere and repealed the sustainable growth rate (SGR) once and for all.

The Cardiovascular Business team embarked on this survey to gain a deeper understanding of the current state of cardiovascular health, the role CVIS plays and the goals cardiovascular leaders have established for the next few years.

This report offers a snapshot of what health system and cardiovascular leaders think. Some of it validates, while some enlightens. It all helps
guide leadership on a data-rich and insightful journey into the future.

When it comes to CVIS strategy across the survey base, C-suite leaders and cardiovascular department heads share the responsibility equally often. But in academic medical centers and multi-hospital systems, the division of power is different.